<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33231793</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>23</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>23</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1437-7772</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Mar</Month></PubDate></JournalIssue><Title>International journal of clinical oncology</Title><ISOAbbreviation>Int J Clin Oncol</ISOAbbreviation></Journal><ArticleTitle>The metabolic syndrome is associated with the risk of urothelial carcinoma from a health examination database.</ArticleTitle><Pagination><StartPage>569</StartPage><EndPage>577</EndPage><MedlinePgn>569-577</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10147-020-01834-3</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The metabolic syndrome was associated with bladder cancer in the previous studies. However, there have no large-scale cohort studies to elucidate the relationship between metabolic syndromes and urothelial carcinoma including urinary bladder urothelial carcinoma (UBUC) and upper tract urothelial carcinoma (UTUC).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We analyze a population-based cohort study by using physical examination data and diagnosis of UC from the Taiwan Cancer Registry Database. Differences in demographic and clinical characteristics among UTUC and non-UTUC groups, UBUC and non-UBUC groups were compared. Odds ratios (ORs) for determining risk factors were estimated through the multiple logistic regression model.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 557,063 records for 211,319 participants which consisted of 31 UTUC and 309 UBUC met the eligibility criteria in this study. Our results showed that female are more likely to develop UTUC than male. As opposed to UTUC, male are more likely to develop UBUC than female. It also showed that participants smoked or chewed betel quid daily are more likely to develop UBUC. Age and estimated glomerular filtration rate (eGFR) are significantly increased the risk of developing UTUC. The association between the eGFR and risk of UTUC is stronger (P&#x2009;&lt;&#x2009;0.001) for eGFR&#x2009;&lt;&#x2009;45 (vs. eGFR&#x2009;&#x2265;&#x2009;75, OR&#x2009;=&#x2009;6.795; 95% CI 2.901-15.917). Metabolic syndrome is related to higher risk of UBUC incidence [OR was 1.373 (95% CI 1.104-1.707)].</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">There was a significant relationship between the incidence of UBUC and metabolic syndrome. Renal function impairment presents higher risk in both UBUC and UTUC development.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Hsiang-Ying</ForeName><Initials>HY</Initials><AffiliationInfo><Affiliation>Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Jia-Hong</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Institute of Statistical Science, Academia Sinica, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yen-Hsu</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Graduate Institute of Medicine, Sepsis Research Center, Center of Dengue Fever Control and Research, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biological Science and Technology, College of Biological Science and Technology, National Chiao Tung University, Hsinchu, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Wen-Jeng</ForeName><Initials>WJ</Initials><AffiliationInfo><Affiliation>Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Juan</LastName><ForeName>Yung-Shun</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Wei-Ming</ForeName><Initials>WM</Initials><AffiliationInfo><Affiliation>Department of Urology, Ministry of Health and Welfare Pingtung Hospital, Pingtung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Ta-Chien</ForeName><Initials>TC</Initials><Identifier Source="ORCID">0000-0002-1685-783X</Identifier><AffiliationInfo><Affiliation>Research Center for Humanities and Social Sciences, Academia Sinica, 128 Academia Road, Section 2, Nankang, Taipei, 115, Taiwan. dachianpig@gmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Public Health, School of Medicine, National Yang-Ming University, Taipei, Taiwan. dachianpig@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>Int J Clin Oncol</MedlineTA><NlmUniqueID>9616295</NlmUniqueID><ISSNLinking>1341-9625</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002295" MajorTopicYN="Y">Carcinoma, Transitional Cell</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D024821" MajorTopicYN="Y">Metabolic Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013624" MajorTopicYN="N" Type="Geographic">Taiwan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Betel quid</Keyword><Keyword MajorTopicYN="N">Metabolic syndrome</Keyword><Keyword MajorTopicYN="N">Renal function</Keyword><Keyword MajorTopicYN="N">Smoking</Keyword><Keyword MajorTopicYN="N">Urothelial carcinoma</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>11</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>24</Day><Hour>12</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33231793</ArticleId><ArticleId IdType="doi">10.1007/s10147-020-01834-3</ArticleId><ArticleId IdType="pii">10.1007/s10147-020-01834-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Torre LA, Bray F, Siegel RL et al (2015) Global cancer statistics, 2012. CA Cancer J Clin 65(2):87&#x2013;108</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.21262</ArticleId></ArticleIdList></Reference><Reference><Citation>Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69(1):7&#x2013;34</Citation><ArticleIdList><ArticleId IdType="doi">10.3322/caac.21551</ArticleId></ArticleIdList></Reference><Reference><Citation>Roupret M, Babjuk M, Comperat E et al (2013) European guidelines on upper tract urothelial carcinomas: 2013 update. Eur Urol 63(6):1059&#x2013;1071</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eururo.2013.03.032</ArticleId></ArticleIdList></Reference><Reference><Citation>Li CC, Chang TH, Wu WJ et al (2008) Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients. Eur Urol 54(5):1127&#x2013;1134</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eururo.2008.01.054</ArticleId></ArticleIdList></Reference><Reference><Citation>Colin P, Koenig P, Ouzzane A et al (2009) Environmental factors involved in carcinogenesis of urothelial cell carcinomas of the upper urinary tract. BJU Int 104(10):1436&#x2013;1440</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1464-410X.2009.08838.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyazaki J, Nishiyama H (2017) Epidemiology of urothelial carcinoma. Int J Urol 24(10):730&#x2013;734</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/iju.13376</ArticleId></ArticleIdList></Reference><Reference><Citation>Stocks T, Bjorge T, Ulmer H et al (2015) Metabolic risk score and cancer risk: pooled analysis of seven cohorts. Int J Epidemiol 44(4):1353&#x2013;1363</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyv001</ArticleId></ArticleIdList></Reference><Reference><Citation>Russo A, Autelitano M, Bisanti L (2008) Metabolic syndrome and cancer risk. Eur J Cancer 44(2):293&#x2013;297</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejca.2007.11.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito K, Chiodini P, Colao A et al (2012) Metabolic syndrome and risk of cancer: a systematic review and meta-analysis. Diabetes Care 35(11):2402&#x2013;2411</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc12-0336</ArticleId></ArticleIdList></Reference><Reference><Citation>Sha N, Xu H, Chen T et al (2016) The evaluation of the association between the metabolic syndrome and tumor grade and stage of bladder cancer in a Chinese population. Onco Targets Ther 9:1175&#x2013;1179</Citation><ArticleIdList><ArticleId IdType="pubmed">27022277</ArticleId><ArticleId IdType="pmc">4789849</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagase K, Tobu S, Kusano S et al (2018) The association between metabolic syndrome and high-stage primary urothelial carcinoma of the bladder. Curr Urol 12(1):39&#x2013;42</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000447229</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallagher EJ, LeRoith D (2013) Epidemiology and molecular mechanisms tying obesity, diabetes, and the metabolic syndrome with cancer. Diabetes Care 36(Suppl 2):S233-239</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dcS13-2001</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L TS, Wang ML et al ( 2016) Technical report of MJ health database. In. Taipei, Taiwan: MJ Health Research Foundation</Citation></Reference><Reference><Citation>Gacci M, Russo GI, Nunzio C et al (2017) Meta-analysis of metabolic syndrome and prostate cancer. Prostate Cancer Prostatic Dis 20(2):146&#x2013;155</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/pcan.2017.1</ArticleId></ArticleIdList></Reference><Reference><Citation>Morlacco A, Dal Moro F, Rangel LJ et al (2018) Impact of metabolic syndrome on oncologic outcomes at radical prostatectomy. Urol Oncol 36(12):528.e1&#x2013;528.e6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.urolonc.2018.10.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Colicchia M, Morlacco A, Rangel LJ et al (2019) Role of metabolic syndrome on perioperative and oncological outcomes at radical prostatectomy in a low-risk prostate cancer cohort potentially eligible for active surveillance. Eur Urol Focus 5(3):425&#x2013;432</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.euf.2017.12.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo S, Oh S, Park J et al (2019) Effects of metabolic syndrome on the prevalence of prostate cancer: historical cohort study using the national health insurance service database. J Cancer Res Clin 145(3):775&#x2013;780</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00432-019-02842-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Kriegmair MC, Mandel P, Porubsky S et al (2017) Metabolic syndrome negatively impacts the outcome of localized renal cell carcinoma. Horm Cancer 8(2):127&#x2013;134</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12672-017-0289-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Micucci C, Valli D, Matacchione G et al (2016) Current perspectives between metabolic syndrome and cancer. Oncotarget 7(25):38959&#x2013;38972</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.8341</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantiello F, Cicione A, Autorino R et al (2014) Visceral obesity predicts adverse pathological features in urothelial bladder cancer patients undergoing radical cystectomy: a retrospective cohort study. World J Urol 32(2):559&#x2013;564</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00345-013-1147-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Haggstrom C, Stocks T, Rapp K et al (2011) Metabolic syndrome and risk of bladder cancer: prospective cohort study in the metabolic syndrome and cancer project (Me-Can). Int J Cancer 128(8):1890&#x2013;1898</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.25521</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S, Zhang GM, Guan FJ et al (2015) The association between metabolic syndrome and the risk of urothelial carcinoma of the bladder: a case&#x2013;control study in China. World J Surg Oncol 13:236. https://doi.org/10.1186/s12957-015-0631-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12957-015-0631-5</ArticleId><ArticleId IdType="pubmed">26246367</ArticleId><ArticleId IdType="pmc">4527224</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozbek E, Otunctemur A, Dursun M et al (2014) Association between the metabolic syndrome and high tumor grade and stage of primary urothelial cell carcinoma of the bladder. Asian Pac J Cancer Prev 15(3):1447&#x2013;1451</Citation><ArticleIdList><ArticleId IdType="doi">10.7314/APJCP.2014.15.3.1447</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki S, Cohen SM, Arnold LL et al (2019) Cotinine, a major nicotine metabolite, induces cell proliferation on urothelium in vitro and in vivo. Toxicology 429:152325</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tox.2019.152325</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao J, Xu R, Zhao XK et al (2016) Areca nut chewing and an impaired estimated glomerular filtration rate as significant risk factors for non-muscle-invasive bladder cancer recurrence. Sci Rep 7(6):29466. https://doi.org/10.1038/srep29466</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep29466</ArticleId></ArticleIdList></Reference><Reference><Citation>Deodutta Roy MTD (2010) Environmental factors, genes, and the development of human cancers. Springer, New York</Citation></Reference><Reference><Citation>Shafique K, Zafar M, Ahmed Z et al (2013) Areca nut chewing and metabolic syndrome: evidence of a harmful relationship. Nutr J 12:67. https://doi.org/10.1186/1475-2891-12-67</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1475-2891-12-67</ArticleId><ArticleId IdType="pubmed">23688186</ArticleId><ArticleId IdType="pmc">3663704</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao J, Zhao X, Zhong Z, Zhang L, Zhu X, Xu R (2016) Prognostic value of pre-operative renal insufficiency in urothelial carcinoma: a systematic review and meta-analysis. Sci Rep 6:35214</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep35214</ArticleId></ArticleIdList></Reference><Reference><Citation>Oldridge J, Karmarkar S (2015) Fluid and electrolyte problems in renal dysfunction. Anaesth Intensive Care Med 16(6):262&#x2013;266</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mpaic.2015.03.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Oberg BP, McMenamin E, Lucas FL et al (2004) Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int 65(3):1009&#x2013;1016</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1523-1755.2004.00465.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen CP, Cheng TY, Tsai MK et al (2008) All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet 371(9631):2173&#x2013;2182</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(08)60952-6</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>